TABLE 4.
Other pregnancy outcomes in the probiotic and placebo group
| Probiotic (n = 25) | Placebo (n = 24) | |
|---|---|---|
| GWG <5 kg, n (%) | 2 (9 %) | 1 (4 %) |
| GWG 5–9 kg, n (%) | 2 (9 %) | 4 (17 %) |
| GWG >9 kg, n (%) | 18 (82 %) | 19 (79 %) |
| Hypertension, n (%) | 6 (24 %) | 5 (21 %) |
| Preeclampsia, n (%) | 3 (12 %) | 3 (12 %) |
| Induction of labor, n (%) | 14 (56 %) | 12 (50 %) |
| Cesarean section, n (%) | 11 (44 %) | 5 (21 %) |
| Gestational age at birth, d ± SD | 274 ± 19 | 280 ± 11 |
| Preterm delivery, n (%) | ||
| Gestational age 28–34 wk | 1 (4 %) | 0 (0 %) |
| Gestational age 34–37 wk | 3 (12 %) | 0 (0 %) |
| Birth weight of all infants, g (mean ± SD) | 3414 ± 676 | 3640 ± 454 |
| Birth weight of PP all infants, g (mean ± SD) | 3320 ± 703 | 3658 ± 428) |
| >4 kg at term, n (%) | 4 (16 %) | 7 (29 %) |
| Small for gestational age, n (%) | 1 (4 %) | 0 (0 %) |
| Large for gestational age, n (%) | 1 (4 %) | 4 (17 %) |
| Male gender, n (%) | 13 (52 %) | 13 (54 %) |
| Antibiotics during pregnancy, n (%) | 6 (24 %) | 5 (21 %) |
| Antibiotics at birth*, n (%) | 7 (28 %) | 12 (50 %) |
GWG, gestational weight gain; PP, per protocol.*Antibiotic treatment at birth was given in cases of premature rupture of the membranes >18 h in accordance with Danish guidelines.